Biblio

Export 7 results:
Author Title Type [ Year(Asc)]
Filters: Author is Bohlken, Jens  [Clear All Filters]
2023
K. Kostev, Gessler, N., Wohlmuth, P., Arnold, D., Bein, B., Bohlken, J., Herrlinger, K., Jacob, L., Koyanagi, A., Nowak, L., Smith, L., Wesseler, C., Sheikhzadeh, S., and Wollmer, M. Axel, “Is Dementia Associated with COVID-19 Mortality? A Multicenter Retrospective Cohort Study Conducted in 50 Hospitals in Germany.”, J Alzheimers Dis, vol. 91, no. 2, pp. 719-726, 2023.
2018
J. Bohlken, Jacob, L., and Kostev, K., “Association Between the Use of Antihyperglycemic Drugs and Dementia Risk: A Case-Control Study.”, J Alzheimers Dis, vol. 66, no. 2, pp. 725-732, 2018.
J. Bohlken, Jacob, L., van den Bussche, H., and Kostev, K., “The Influence of Polypharmacy on the Initiation of Anti-Dementia Therapy in Germany.”, J Alzheimers Dis, vol. 64, no. 3, pp. 827-833, 2018.
J. Bohlken and Kostev, K., “Relevance of Coded Prodromal Mild Cognitive Impairment in the Routine Treatment of Patients with Dementia in Germany.”, J Alzheimers Dis, vol. 65, no. 2, pp. 393-399, 2018.
2017
J. Bohlken, Jacob, L., and Kostev, K., “Association between Anti-Dementia Treatment Persistence and Daily Dosage of the First Prescription: A Retrospective Analysis in Neuropsychiatric Practices in Germany.”, J Alzheimers Dis, vol. 58, no. 1, pp. 37-44, 2017.
L. Jacob, Bohlken, J., and Kostev, K., “Prevalence of Use of Cardiovascular Drugs in Dementia Patients Treated in General Practices in Germany.”, J Alzheimers Dis, vol. 56, no. 4, pp. 1519-1524, 2017.
L. Jacob, Bohlken, J., and Kostev, K., “Risk Factors for Mild Cognitive Impairment in German Primary Care Practices.”, J Alzheimers Dis, vol. 56, no. 1, pp. 379-384, 2017.